Research progress on neutralizing epitopes and antibodies for the Rabies virus
Rabies is a zoonotic infectious disease with a high fatality rate. It is caused by a virus in the genus Lyssavirus and is a global public health threat. The rabies virus invades and infects cells mainly via a glycoprotein, which may involve multiple receptors. Neutralizing antibodies against the rab...
Main Authors: | Chenjuan Shi, Peilu Sun, Pan Yang, Lele Liu, Li Tian, Wenkai Liu, Min Wang, Xuexing Zheng, Wenwen Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Infectious Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772431X22000429 |
Similar Items
-
Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates
by: Chenjuan Shi, et al.
Published: (2022-12-01) -
Antigenic variations of recent street rabies virus
by: Wenbo Wang, et al.
Published: (2019-01-01) -
Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein
by: Kohei Yumoto, et al.
Published: (2021-11-01) -
Functional epitopes and neutralizing antibodies of vaccinia virus
by: Fenghao Peng, et al.
Published: (2023-10-01) -
Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines
by: Avelino Albas, et al.
Published: (1998-08-01)